2023-11-13T12:20:26-06:00 2022-12-31 521711839 COUNCILOR BUCHANAN & MITCHELL PC 7910 WOODMONT AVE STE 500 BETHESDA MD 20814 990 2022-01-01 522252820 ASSOCIATION FOR ACCESSIBLE MEDICINES ASSO 2022497100 601 NEW JERSEY AVENUE NW 850 WASHINGTON DC 20001 DAVID GAUGH INTERIM CHIEF EXECUTIVE OFFICER 2022497100 2023-11-12 1 DAVID GAUGH 999009999 1 MARK THOMAS P00362982 3019860600 2023-11-12 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z DAVID GAUGH 601 NEW JERSEY AVENUE NW 850 WASHINGTON DC 20001 23253240 0 X WWW.ACCESSIBLEMEDS.ORG X 2000 DC PROMOTE THE INTEREST OF THE GENERIC PHARMACEUTICAL AND BIOSIMILAR INDUSTRY. 24 24 36 275 0 0 0 0 25453104 22237409 58057 18658 11823 405939 25522984 22662006 271108 275700 0 0 10974580 10900171 0 0 0 12327857 13675570 23573545 24851441 1949439 -2189435 18090132 27489220 8691351 20279874 9398781 7209346 THE ORGANIZATION FOSTERS AND PROMOTES THE INTERESTS OF THE GENERIC PHARMACEUTICAL AND BIOSIMILARS INDUSTRY. 0 0 GOVERNMENT AFFAIRS - ADVOCATE ON BEHALF OF THE GENERIC PHARMACEUTICAL AND BIOSIMILARS INDUSTRY WITH RESPECT TO FEDERAL, STATE, AND MUNICIPAL RULES, LAWS, AND ORDERS AFFECTING THE INDUSTRY. POLICY & STRATEGIC ALLIANCES - IDENTIFY POLICY ISSUES AFFECTING THE GENERIC DRUG AND BIOSIMILARS INDUSTRIES AND FACILITATE DEVELOPMENT OF POLICY POSITIONS AMONG OUR MEMBER COMPANIES; WORK WITH THE AGENCIES OF THE U.S. GOVERNMENT, AND STATE AND INTERNATIONAL BODIES TO EDUCATE AND COMMUNICATE POLICY POSITIONS ON STRATEGIC PRIORITIES; DEVELOP DATA TO SUPPORT ADVOCACY INITIATIVES AND PUBLISH WHITE PAPERS, REPORTS AND OTHER POLICY RESOURCES; BUILD RELATIONSHIPS WITH THIRD-PARTY STAKEHOLDERS ACROSS SUPPLY CHAIN, PATIENT, PROVIDER, CONSUMER, AND OTHER SECTORS TO SUPPORT ADVOCACY INITIATIVES. COMMUNICATIONS & MARKETING - EDUCATING POLICYMAKERS, MEDIA, PATIENTS AND OTHER STAKEHOLDERS ABOUT THE ECONOMIC AND THERAPEUTIC CONTRIBUTIONS OF GENERIC AND BIOSIMILARS MEDICINES AS WELL AS THEIR SAFETY AND EFFICACY; PRODUCING AND SHARING PATIENT AND TAXPAYER SAVINGS DATA AND STORIES OF PATIENTS WHOSE HEALTH IS SAVED, IMPROVED AND MAINTAINED BY GENERIC AND BIOSIMILARS MEDICINES; DISSEMINATING INSTRUCTIONAL MATERIALS AND CURRICULUM TO PROMOTE THE SAFE USE, STORAGE AND DISPOSAL OF PRESCRIPTION MEDICINES. 0 0 0 1 0 0 0 0 0 1 1 0 1 1 1 0 1 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 71 0 1 36 1 0 0 0 0 0 0 0 0 0 0 X 24 24 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 X THE ASSOCIATION 2022497100 601 NEW JERSEY AVE NW SUITE 850 WASHINGTON DC 20001 PATEL CHIRAG CHAIR 2.00 X X 0 0 0 BAEDER CHRISTINE VICE CHAIR 2.00 X X 0 0 0 HOFFMANN BRIAN TREASURER OCT-DEC 2.00 X X 0 0 0 HAMPTON JEFF DIRECTOR 2.00 X 0 0 0 DIOLOSA PAUL DIRECTOR 2.00 X 0 0 0 DISCHNER DAN DIRECTOR 2.00 X 0 0 0 MCMAHON PAUL DIRECTOR 2.00 X 0 0 0 VERMA ARUNESH DIRECTOR 2.00 X 0 0 0 BRILL VANESSA DIRECTOR 2.00 X 0 0 0 DUCKER JOHN DIRECTOR 2.00 X 0 0 0 KRISHAN SANJEEV DIRECTOR 2.00 X 0 0 0 FULLEM TERRY TREASURER JAN-SEPT 2.00 X X 0 0 0 PANDYA HEM DIRECTOR 2.00 X 0 0 0 MANCINELLI VINCENT DIRECTOR 2.00 X 0 0 0 KAEMMERER PETER DIRECTOR 2.00 X 0 0 0 HARUVI KEREN DIRECTOR 2.00 X 0 0 0 FISHER CRYSTAL DIRECTOR 2.00 X 0 0 0 GUPTA SANJAY DIRECTOR 2.00 X 0 0 0 GANDHI ABHAY DIRECTOR 2.00 X 0 0 0 SHEA TOM DIRECTOR 2.00 X 0 0 0 SONIG ALOK DIRECTOR 2.00 X 0 0 0 FORTIER KEVIN DIRECTOR 2.00 X 0 0 0 CHIGURUPATI KRISHNA DIRECTOR 2.00 X 0 0 0 ALBERT ROB DIRECTOR 2.00 X 0 0 0 HARDWICK PETER DIRECTOR 2.00 X 0 0 0 BURD JEFF DIRECTOR 2.00 X 0 0 0 HOFFMAN BOB DIRECTOR 2.00 X 0 0 0 FRANCER JEFFREY SECRETARY(1/22-6/22),SVP/GEN COUNSEL 40.00 X 491416 0 34193 GAUGH DAVID INTERIM PRESIDENT & CEO/SVP SCIENCES & REGULATORY 40.00 X 638420 0 48061 LEONARD DANIEL PRESIDENT & CEO 40.00 X 1228689 0 140496 DUNCAN JOANNE SECRETARY (7/22-12/22); COO 40.00 X 461017 0 35700 SIMMON CHRISTINE EVP, POLICY AND STRATEGIC ALLIANCES 40.00 X 214289 0 18733 GOLDBERG ALLEN SVP, COMMUNICATIONS 40.00 X 476470 0 53543 KIMBALL JONATHAN VP TRADE, INTERNATIONAL & STRATEGIC AFFAIRS 40.00 X 370198 0 50131 KOMENDANT ERIK SVP GOVERNMENT AFFAIRS 40.00 X 452446 0 39981 BURTON CRAIG SVP POLICY & STRATEGIC ALLIANCES 40.00 X 388128 0 48875 HESSLER KARIN GENERAL COUNSEL 40.00 X 368193 0 32200 5089266 0 501913 26 0 1 0 FIREHOUSE STRATEGIES 1501 M STREET NW SUITE 1100 WASHINGTON DC 20005 CONSULTING SERVICES 627000 KIRKLAND & ELLIS 601 LEXINGTON AVENUE NEW YORK NY 10022 LEGAL SERVICES 620433 AVALERE HEALTH 1201 NEW YORK AVENUE NW SUITE 1000 WASHINGTON DC 20005 ANALYTIC SERVICES 544000 IQVIA INC 100 IMS DRIVE PARSIPPANY NJ 07054 RESEARCH STUDIES 505684 MODEL B 900 7TH ST 970 WASHINGTON DC 20001 DIGITAL STRATEGIES 495227 34 MEMBERSHIP DUES 999009 20349470 20349470 MEETING REVENUE 999009 1117939 1117939 BIOSIMILAR COUNCIL DUES 999009 570000 570000 RECOVERY OF LITIGATION EXPENSES 999009 200000 200000 22237409 52672 52672 390635 0 390635 390635 390635 557220 591234 -34014 -34014 -34014 MISCELLANEOUS 999009 15304 15304 15304 22662006 22252713 0 409293 X 275700 3311015 6040884 652294 446826 449152 2062207 105975 2786667 3328024 881836 225448 316847 1307524 191664 998911 280972 52102 RESEARCH PROJECT 540171 DUES & SUBSCRIPTIONS 526629 MISCELLANEOUS 70593 24851441 4915002 9388789 7522764 6890189 121396 119978 286782 478899 2744814 1622298 1403488 1122516 592059 413257 3241521 3247147 0 0 7120 5828445 18090132 27489220 1345624 1121082 4738049 10696433 2607678 8462359 8691351 20279874 X 9398781 7209346 9398781 7209346 18090132 27489220 -2189435 0 X X 0 1 X 1 0 0 0 0 20919470 5643400 -12198981 -6555581 7520009 -14075590 1752500 845663 906837 879038 663359 215679 113276 113276 0 1122516 CERTIFICATE OF DEPOSITS 3247147 C 3247147 DEPOSITS 28097 OPERATING RIGHT-OF-USE ASSETS 5800348 5828445 DEFERRED COMPENSATION PAYABLE 413257 OPERATING LEASE LIABILITIES 8049102 8462359 X PART X, LINE 2: THE ASSOCIATION REQUIRES THAT A TAX POSITION BE RECOGNIZED OR DERECOGNIZED BASED ON A "MORE-LIKELY-THAN-NOT" THRESHOLD. THIS APPLIES TO POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THE ASSOCIATION DOES NOT BELIEVE ITS FINANCIAL STATEMENTS INCLUDE, OR REFLECT, ANY UNCERTAIN TAX POSITIONS. 0 AFPE 6076 FRANCONIA ROAD SUITE C ALEXANDRIA VA 22310 530214882 501C3 10000 0 GENERAL CONTRIBUTION ALLIANCE FOR RETIRED AMERICANS 815 16TH STREET NW 4TH FLOOR NORTH WASHINGTON DC 20006 522277805 501C3 15000 0 GENERAL CONTRIBUTION AMERICAN CONSUMER INSTITUTE CCR 1701 PENNSYLVANIA AVENUE NW SUITE 200 WASHINGTON DC 20006 208601897 501C3 15000 0 GENERAL CONTRIBUTION AMERICAN PHARMACISTS ASSOCIATION 2215 CONSTITUTION AVENUE NW WASHINGTON DC 20037 530026265 501C6 25000 0 GENERAL CONTRIBUTION CITIZENS AGAINST GOVERNMENT WASTE 1100 CONNECTICUT AVENUE NW SUITE 650 WASHINGTON DC 20036 521363952 501C3 15000 0 GENERAL CONTRIBUTION CONSUMER ACTION 57 POST STREET SUITE 611 SAN FRANCISCO CA 94104 237172908 501C3 12500 0 GENERAL CONTRIBUTION NATIONAL CONSUMERS LEAGUE 1701 K STREET NW WASHINGTON DC 20006 530242038 501C3 15000 0 GENERAL CONTRIBUTION NATIONAL MULTIPLE SCLEROSIS SOCIETY 900 SOUTH BROADWAY 2ND FLOOR DENVER CO 80209 135661935 501C3 7500 0 GENERAL CONTRIBUTION NATIONAL TAXPAYERS UNION 122 C STREET NW SUITE 650 WASHINGTON DC 20001 521009116 501C4 25000 0 GENERAL CONTRIBUTION PREVENT CANCER FOUNDATION 1600 DUKE STREET SUITE 500 ALEXANDRIA VA 22314 521429544 501C3 10000 0 GENERAL CONTRIBUTION R STREET INSTITUTE 1212 NEW YORK AVENUE NW SUITE 900 WASHINGTON DC 20005 263477125 501C3 15000 0 GENERAL CONTRIBUTION TAXPAYERS PROTECTION ALLIANCE 1401 K STREET NW SUITE 502 WASHINGTON DC 20005 450702828 501C4 10000 0 GENERAL CONTRIBUTION THIRD WAY FOUNDATION 1200 NEW HAMPSHIRE AVENUE NW WASHINGTON DC 20036 521629221 501C3 15000 0 GENERAL CONTRIBUTION US CHAMBER OF COMMERCE PO BOX 825448 PHILADELPHIA PA 19182 530045720 501C6 75000 0 GENERAL CONTRIBUTION 10 4 X X X 1 1 X X X X X X 1 1 0 LEONARD DANIEL PRESIDENT & CEO 765308 0 0 0 463381 0 99161 0 41335 0 1369185 0 74761 0 GAUGH DAVID INTERIM PRESIDENT & CEO/SVP SCIENCES 457030 0 181390 0 0 0 24400 0 23661 0 686481 0 0 0 GOLDBERG ALLEN SVP, COMMUNICATIONS 352315 0 124155 0 0 0 21815 0 31728 0 530013 0 0 0 FRANCER JEFFREY SECRETARY(1/22-6/22),SVP/GEN COUNSEL 229525 0 52378 0 209513 0 18566 0 15627 0 525609 0 0 0 DUNCAN JOANNE SECRETARY (7/22-12/22); COO 461017 0 0 0 0 0 10027 0 25673 0 496717 0 0 0 KOMENDANT ERIK SVP GOVERNMENT AFFAIRS 334636 0 117810 0 0 0 20500 0 19481 0 492427 0 0 0 BURTON CRAIG SVP POLICY & STRATEGIC ALLIANCES 281903 0 106225 0 0 0 18272 0 30603 0 437003 0 0 0 KIMBALL JONATHAN VP TRADE, INTERNATIONAL & STRATEGIC 283748 0 86450 0 0 0 21676 0 28455 0 420329 0 0 0 HESSLER KARIN GENERAL COUNSEL 252193 0 116000 0 0 0 17423 0 14777 0 400393 0 0 0 SIMMON CHRISTINE EVP, POLICY AND STRATEGIC ALLIANCES 214289 0 0 0 0 0 10702 0 8031 0 233022 0 0 0 PART I, LINES 4A-B DURING THE YEAR ENDED DECEMBER 31, 2022, DANIEL LEONARD AND JEFFREY FRANCER RECEIVED SEVERANCE PAYMENTS OF $388,620 AND $209,513, RESPECTIVELY. DURING THE YEAR ENDED DECEMBER 31, 2022, DANIEL LEONARD RECEIVED A DISTRIBUTION FROM A 457(F) SUPPLEMENTAL NON-QUALIFIED RETIREMENT PLAN OF $74,761 THAT WAS INCLUDED IN REPORTABLE WAGES FORM 990, PART VI, SECTION A, LINE 6 AAM HAS ONE CLASS OF REGULAR VOTING MEMBERS THAT MUST MEET THE FOLLOWING CRITERIA. A REGULAR MEMBER SHALL BE A CORPORATION, PARTNERSHIP OR OTHER LEGAL ENTITY THAT DERIVES MORE THAN TWENTY-FIVE PERCENT (25%) OF ITS NET REVENUES IN THE UNITED STATES FROM THE DEVELOPMENT, COMMERCIALIZATION, MANUFACTURE, SALE AND/OR MARKETINGS OF FINISHED DOSE PRODUCTS THAT ARE (1) PRODUCTS DESCRIBED IN ABBREVIATED NEW DRUG APPLICATIONS FILED WITH THE U.S. FOOD & DRUG ADMINISTRATION; (2) PRODUCTS SOLD AS AUTHORIZED GENERIC DRUGS IN THE U.S., (3) BIOSIMILAR PRODUCTS, AS DESCRIBED IN SECTION 351(K) OF THE PUBLIC HEALTH SERVICE ACT, AS AMENDED; AND/OR (4) DRUG EFFICACY STUDY IMPLEMENTATION (DESI) PRODUCTS. REGULAR MEMBERS HAVE FULL VOTING RIGHTS ON A "ONE COMPANY, ONE VOTE" BASIS. EACH REGULAR MEMBER SHALL DESIGNATE IN WRITING ONE PERSON TO EXERCISE THE RIGHTS OF THE REGULAR MEMBER IN THIS ASSOCIATION. FORM 990, PART VI, SECTION A, LINE 7A AAM'S VOTING MEMBERS ELECT THE DIRECTORS OF AAM'S BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7B PURSUANT TO AAM'S BYLAWS, AAM'S BOARD OF DIRECTORS HAVE THE AUTHORITY TO AMEND THE BYLAWS. FURTHER, PURSUANT TO THE D.C. NOT-FOR-PROFIT CORPORATION ACT, EXTRAORDINARY ACTIONS MUST BE APPROVED BY THE VOTING MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B AAM STAFF AND LEGAL COUNSEL PROVIDE INITIAL REVIEW OF THE FORM 990. THE FORM 990 IS THEN REVIEWED BY THE AUDIT & FINANCE COMMITTEE. FINALLY IT IS FORWARDED TO ALL THE DIRECTORS OF THE BOARD BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C AAM REGULARLY AND CONSISTENTLY MONITORS COMPLIANCE WITH ITS CONFLICT OF INTEREST POLICY BY REMINDING DIRECTORS AND OTHERS SUBJECT TO THE POLICY PERIODICALLY OF THE APPLICABILITY OF THE POLICY AND THE APPROPRIATE MANNER OF COMPLYING WITH THE POLICY. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION OF THE PRESIDENT IS DETERMINED BASED ON THE PERFORMANCE OF THE PRESIDENT AND COMPARABLE SALARIES OF EXECUTIVES OF SIMILARLY SITUATED AND COMPETING TRADE ASSOCIATIONS IN THE WASHINGTON, DC METROPOLITAN AREA. COMPENSATION OF OTHER OFFICERS AND KEY EMPLOYEES IS DETERMINED BY THE PRESIDENT BASED ON COMPENSATION DATA OF SIMILARLY SITUATED EMPLOYEES AT SIMILARLY SITUATED AND COMPETING TRADE ASSOCIATIONS IN THE WASHINGTON, DC METROPOLITAN AREA. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTANTS 2,977,416. PAYROLL PROCESSING FEES 7,244. BOARD DIRECTED SPECIAL PROJECTS 343,364. FORM 990, PART XII, LINE 2C: THE FINANCE AND AUDIT COMMITTEE OF THE BOARD OVERSEES THE AUDIT AND RECOMMENDS SELECTION OF AN INDEPENDENT AUDITOR BY THE BOARD. THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR. ASSOCIATION FOR ACCESSIBLE MEDICINES EDUCATION FOUNDATION 601 NEW JERSEY AVE NW SUITE 850 WASHINGTON DC 20001 453526383 SEE PART VII - SUPPLEMENTAL INFORMATION DC 501(C)(3) LINE 7 ASSOCIATION FOR ACCESSIBLE MEDICINES 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0